Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

The US’s pharmaceutical lobby has told the Trump White House Australia is failing to adequately protect American patents and ...

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Australia has bluntly warned US President Donald Trump that the Pharmaceutical Benefits scheme is “not up for negotiation” in ...

Among the highlights: The biotech pharma group visited a couple of major pharmaceutical companies, the Sneaky Good Trek involved exploring a career in human resources at a well-known brewery, and ...

The business, which specialises in human challenge trials, has carved out a significant position in drug development in an ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...